These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 37377906)

  • 1. The role of MRI after neochemoradiotherapy in predicting pathological tumor regression grade and clinical outcome in patients with locally advanced rectal adenocarcinoma.
    Niu S; Chen Y; Peng F; Wen J; Xiong J; Yang Z; Peng J; Bao Y; Ding L
    Front Oncol; 2023; 13():1118518. PubMed ID: 37377906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Value of Tumor Regression Grade on MR in Rectal Cancer: A Large-Scale, Single-Center Experience.
    Yoen H; Park HE; Kim SH; Yoon JH; Hur BY; Bae JS; Kim JH; Oh HJ; Han JK
    Korean J Radiol; 2020 Sep; 21(9):1065-1076. PubMed ID: 32691542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance tumour regression grade and pathological correlates in patients with rectal cancer.
    Jang JK; Lee JL; Park SH; Park HJ; Park IJ; Kim JH; Choi SH; Kim J; Yu CS; Kim JC
    Br J Surg; 2018 Nov; 105(12):1671-1679. PubMed ID: 29893988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between MRI and pathology in the assessment of tumour regression grade in rectal cancer.
    Sclafani F; Brown G; Cunningham D; Wotherspoon A; Mendes LST; Balyasnikova S; Evans J; Peckitt C; Begum R; Tait D; Tabernero J; Glimelius B; Roselló S; Thomas J; Oates J; Chau I
    Br J Cancer; 2017 Nov; 117(10):1478-1485. PubMed ID: 28934761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of magnetic resonance tumour regression grade in the prediction of regression and survival of rectal adenocarcinoma after long-course chemoradiotherapy: a cohort study.
    Chen HLR; Seow-En I; Chok AY; Ngo NT; Cheng TL; Tan KE
    Ann Med Surg (Lond); 2023 Apr; 85(4):842-848. PubMed ID: 37113901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modest agreement between magnetic resonance and pathological tumor regression after neoadjuvant therapy for rectal cancer in the real world.
    Achilli P; Magistro C; Abd El Aziz MA; Calini G; Bertoglio CL; Ferrari G; Mari G; Maggioni D; Peros G; Tamburello S; Coppola E; Spinelli A; Grass F; Martin D; Hahnloser D; Salvatori A; De Simoni S; Sheedy SP; Fletcher JG; Larson DW
    Int J Cancer; 2022 Jul; 151(1):120-127. PubMed ID: 35191540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance imaging tumor response score (mrTRS) predicts therapeutic effect and prognosis of locally advanced rectal cancer after neoadjuvant chemoradiotherapy: A prospective, multi-center study.
    Guan Z; Sun RJ; Cao WT; Zhang HM; Yu T; Yu XP; Zhang JX; Zhang XY; Li XT; Zhou ZY; Zhao XM; Wen L; Sun YS
    Radiother Oncol; 2020 Oct; 151():288-295. PubMed ID: 32890612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Predictive value of combination of MRI tumor regression grade and apparent diffusion coefficient for pathological complete remission after neoadjuvant treatment of locally advanced rectal cancer].
    Xu N; Huang FC; Li WL; Luan X; Jiang YM; He B
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Apr; 24(4):359-365. PubMed ID: 33878826
    [No Abstract]   [Full Text] [Related]  

  • 9. Utility of ctDNA in predicting response to neoadjuvant chemoradiotherapy and prognosis assessment in locally advanced rectal cancer: A prospective cohort study.
    Wang Y; Yang L; Bao H; Fan X; Xia F; Wan J; Shen L; Guan Y; Bao H; Wu X; Xu Y; Shao Y; Sun Y; Tong T; Li X; Xu Y; Cai S; Zhu J; Zhang Z
    PLoS Med; 2021 Aug; 18(8):e1003741. PubMed ID: 34464382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PAN-EX: a pooled analysis of two trials of neoadjuvant chemotherapy followed by chemoradiotherapy in MRI-defined, locally advanced rectal cancer.
    Sclafani F; Brown G; Cunningham D; Wotherspoon A; Tait D; Peckitt C; Evans J; Yu S; Sena Teixeira Mendes L; Tabernero J; Glimelius B; Cervantes A; Thomas J; Begum R; Oates J; Chau I
    Ann Oncol; 2016 Aug; 27(8):1557-65. PubMed ID: 27217542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI tumour regression grade in locally recurrent rectal cancer.
    Voogt ELK; Nordkamp S; van Zoggel DMGI; Daniëls-Gooszen AW; Nieuwenhuijzen GAP; Bloemen JG; Creemers GJ; Cnossen JS; van Lijnschoten G; Burger JWA; Rutten HJT; Nederend J
    BJS Open; 2022 May; 6(3):. PubMed ID: 35552373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rectal cancer feasibility study with an embedded phase III trial design assessing magnetic resonance tumour regression grade (mrTRG) as a novel biomarker to stratify management by good and poor response to chemoradiotherapy (TRIGGER): study protocol for a randomised controlled trial.
    Battersby NJ; Dattani M; Rao S; Cunningham D; Tait D; Adams R; Moran BJ; Khakoo S; Tekkis P; Rasheed S; Mirnezami A; Quirke P; West NP; Nagtegaal I; Chong I; Sadanandam A; Valeri N; Thomas K; Frost M; Brown G
    Trials; 2017 Aug; 18(1):394. PubMed ID: 28851403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative concurrent chemoradiotherapy MRI characteristics favouring pathologic complete response in patients with rectal cancer: Usefulness of MR T2-stage as an ancillary finding for predicting pathologic complete response.
    Lee HJ; Chung WS; An JH; Kim JH
    J Med Imaging Radiat Oncol; 2021 Apr; 65(2):166-174. PubMed ID: 33319450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognosis and complications of local excision for rectal cancer after neoadjuvant chemoradiotherapy].
    Li YH; Qiu XY; Lin GL; Zhou JL; Xiao Y; Qiu HZ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Apr; 24(4):344-351. PubMed ID: 33878824
    [No Abstract]   [Full Text] [Related]  

  • 15. MRI Tumor Regression Grade Combined with T2-Weighted Volumetry May Predict Histopathological Response in Locally Advanced Rectal Cancer following Neoadjuvant Chemoradiotherapy-A New Scoring System Proposal.
    Jankovic A; Kovac JD; Dakovic M; Mitrovic M; Saponjski D; Milicevic O; Djuric-Stefanovic A; Barisic G
    Diagnostics (Basel); 2023 Oct; 13(20):. PubMed ID: 37892047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modified 3-Point MRI-Based Tumor Regression Grade Incorporating DWI for Locally Advanced Rectal Cancer.
    Lee MA; Cho SH; Seo AN; Kim HJ; Shin KM; Kim SH; Choi GS
    AJR Am J Roentgenol; 2017 Dec; 209(6):1247-1255. PubMed ID: 28981353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defining response to radiotherapy in rectal cancer using magnetic resonance imaging and histopathological scales.
    Siddiqui MR; Bhoday J; Battersby NJ; Chand M; West NP; Abulafi AM; Tekkis PP; Brown G
    World J Gastroenterol; 2016 Oct; 22(37):8414-8434. PubMed ID: 27729748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Value of Tumor Volume, Tumor Volume Reduction Rate and Magnetic Resonance Tumor Regression Grade in Rectal Cancer.
    Pikūnienė I; Strakšytė V; Basevičius A; Žilinskas J; Ambrazienė R; Jančiauskienė R; Saladžinskas Ž
    Medicina (Kaunas); 2023 Dec; 59(12):. PubMed ID: 38138297
    [No Abstract]   [Full Text] [Related]  

  • 19. Prospective evaluation of MR-TRG (Tumor Regression Grade) in esophageal cancer after neo-adjuvant therapy: Preliminary results.
    Chapellier P; Fasquelle F; Saglietti C; Kinj R; Mantziari S; Schäfer M; Haefliger L; Jreige M; Vietti Violi N; Sempoux C; Dromain C
    Eur J Radiol; 2024 Feb; 171():111263. PubMed ID: 38159523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. College of American Pathologists Tumor Regression Grading System for Long-Term Outcome in Patients with Locally Advanced Rectal Cancer.
    Chen HY; Feng LL; Li M; Ju HQ; Ding Y; Lan M; Song SM; Han WD; Yu L; Wei MB; Pang XL; He F; Liu S; Zheng J; Ma Y; Lin CY; Lan P; Huang MJ; Zou YF; Yang ZL; Wang T; Lang JY; Orangio GR; Poylin V; Ajani JA; Wang WH; Wan XB
    Oncologist; 2021 May; 26(5):e780-e793. PubMed ID: 33543577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.